Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 23Withdrawn 3Unknown 3Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 3Nausea 3Vomiting 2Neoplasm Metastasis 2Triple Negative Breast Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Gynecologic Cancer 1Carcinoma 1

Interventions

Dexamethasone 6fosaprepitant 4Calcium Dobesilate 4Aprepitant 4dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Palonosetron 2Ondansetron 2Granisetron 2Cisplatin 2dolasetron 1casopitant 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Neoadjuvant Therapy 1Methadone 1Lorazepam 1Interviews as Topic 1Immunoenzyme Techniques 1Esomeprazole 1Diphenhydramine 1Cyproheptadine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Vomiting × Ondansetron × Clear all
NCT00285051 2020-12-23

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Rafa Laboratories

Phase 2 Terminated
6 enrolled

Nausea, Neoplasms, Vomiting

NCT00429702 2014-07-25

Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy

University of South Florida

Phase 2 Terminated
7 enrolled 6 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡